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Objective: Conventional laparoscopic myomectomy (LM) has inherent limitations due to its rigid struc-
ture. The robotic system is a newly developed technology equipped with a ﬂexible EndoWrist that offers
good performance in delicate motions. Our objective was to share our clinical experience in the man-
agement of complex myomectomy using this robotic system.
Materials and methods: From October 2010 to March 2012, 21 patients with symptomatic complex
uterine myomas were evaluated. Complex myomectomy was deﬁned as surgery involving more than two
ﬁbroids, large ﬁbroids, or preexisting pelvic adhesions. We recorded and analyzed the preoperative
characteristics of the patients and the ﬁbroids, the detailed surgical time, and several postoperative
outcomes to evaluate the feasibility and efﬁcacy of robotic-assisted LM (RALM) for complex ﬁbroids.
Results: A total of 21 patients were enrolled in this study. The mean age of the patients was 40.1 ± 4.5
years and the mean size of the largest ﬁbroid was 7.3 ± 3.5 cm. RALM achieved satisfactory results,
including a short postoperative hospital stay (3.1 ± 0.9 days), a low conversion rate (none of our patients
required conversion to either a minilaparotomy or conventional open surgery), and a low complication
rate (1 case in 21 patients, 4.8%). The average estimated blood loss was 235.7 ± 283.3 mL.
Conclusion: Our study results demonstrated that RALM is a safe and effective method for handling
complex ﬁbroids.
Copyright © 2014, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Laparoscopic surgery has been embraced by gynecologic sur-
geons for decades. Compared with laparotomy, laparoscopic sur-
gery usually has the advantages of shorter hospitalization, faster
recovery, less morbidity, and better cosmetic outcome [1,2]. In
recent years, the increasing demand for myomectomy has reﬂected
the desire for expanded fertility associated with the prevalence of
delayed marriage and childbearing [3]. As a consequence, the use of
laparoscopic myomectomy (LM) has been expanding because itand Gynecology, Taipei Vet-
Pai Road, Taipei 112, Taiwan;
mber 155, Section 2, Li-Nong
hotmail.com (Y.-J. Chen).
bstetrics & Gynecology. Publishedprovides a good alternative therapy to laparotomy [4]. However, LM
is technically more difﬁcult than abdominal myomectomy, espe-
cially in surgeries involving more than two ﬁbroids, large ﬁbroids,
and pelvic adhesions. This is attributed to some technical limita-
tions associated with using such a rigid instrument, including dif-
ﬁculties in identifying an appropriate pseudocapsule plane and
performing a strong and layered closure for the uterine incisions
[5].
Robotic surgical systems are expected to provide a solution to
overcome these shortcomings [6,7]. The da Vinci robotic surgical
system was developed for laparoscopic surgery in 2000 and
approved by the U.S. Food and Drug Administration in 2005 for use
in gynecologic surgery. With advanced EndoWrist technology, ro-
botic systems offer surgeons natural dexterity and the wide-angled
motion of joints, such as those in the human hand and wrist [8].
Using a three-dimensional, high-deﬁnition visual system offers aby Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Port placement. Point A, 12-mm camera port through the LeeeHuang point
(located in the middle upper abdomen between the xiphoid process and umbilicus).
Points BeD, 8-mm ports for robotic arms. Point E, 12-mm assistant port. The intervals
between successive trocars are all approximately 10 cm.
Table 1
Patient and ﬁbroid characteristics.
Age (y) 40.1 ± 4.5
Body mass index (kg/m2) 24.1 ± 4.4
History of abdominal surgery 4 (19.0%)
Adhesion lysis 3 (14.3.0%)
Fibroids
Numbera 3.1 (1.0e17.0)
Size of largest (cm)b 7.3 ± 3.5 (2.0e17.9)
Weight (g)b 367.4 ± 317.7 (10e1070)
Location within uterus, n (%)
Anterior 17 (81.0%)
Posterior 9 (42.9%)
Fundal 10 (47.6%)
Broad ligament 0
a Value is expressed as the mean (minimumemaximum).
b Data are shown as the mean ± standard deviation (minimumemaximum).
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vantages, robotic technology appears to overcome the limitations
inherent in traditional laparoscopy and promote the endoscopic
surgical performance of myomectomy [9], especially in cases with
complicated conditions such as largemyomas, multiple myomas, or
pelvic adhesions formed between the uterus and adjacent tissues
and organs.
In October 2010, we began assessing robotic-assisted LM
(RALM) in a prospective setup. This study describes our clinical
experience in managing complex myomectomies in 21 consecutive
patients, focusing on the feasibility and potential advantages as
well as the pitfalls and challenges of using RALM.
Materials and methods
From October 2010 to March 2012, 37 patients underwent
robotic-assisted surgery at a tertiary medical center in northern
Taiwan. Of these, 22 patients were diagnosed with symptomatic
complex uterine myomas and underwent RALM surgery. Complex
myomectomy was deﬁned as surgery involving more than two ﬁ-
broids, large ﬁbroids (diameter 8 cm), or preexisting pelvic ad-
hesions. All patients were operated on consecutively using the da
Vinci Si robotic surgical system (Intuitive Surgical Inc., Sunnyvale,
CA, USA) at our institution. Preoperative characteristics and post-
operative data of the 22 patients were screened. One patient
received not only a myomectomy but also a bilateral salpingectomy
and adhesiolysis for severe pelvic adhesion and was therefore
excluded from the study. All surgical procedures were performed
by a single surgeon, according to the procedure described in the
following section.
Under general anesthesia, the patients were placed in the
Trendelenburg position, with a urinary catheter and uterine
manipulator (Kronner Medical Mfg., Roseburg, Oregon, United
States) placed before the surgery. After pneumoperitoneum was
created by CO2 insufﬂation pressure using a transumbilical Veress
needle, ﬁve bladeless trocars were placed in the patient's abdomen
as follows: one 12-mm central port, three 8-mm ports for the ro-
botic arms, and with one additional 12-mm port for the assistant
(Fig. 1). Following the docking of the robotic arms, the three-
dimensional zero-degree stereoscopic endoscope and EndoWrist
instruments were then inserted into the robotic ports, including
monopolar scissors, PK forceps, and a large/mega needle driver
(Intuitive Surgical Inc.). Then, the surgeon moved to the console to
control the robot remotely. Vasopressin (30 m/mL diluted in 90 mL
saline solution) was injected at various points on the dome of the
uterus and at the region of attachment of the uterus to the myoma.
After enucleation of the myomas, the myometrial edges were
reapproximated in two-layer sutures with interrupted ﬁgure-eight
intracorporeal knots (Polysorb 0). The left lower quadrant port was
then converted into the insertion site of the morcellator (Karl Storz,
Tuttlingen, Baden-Württemberg, Germany). The morcellation and
extraction of the excised myomas were executed using the tradi-
tional laparoscopic method after disassembling the robotic system.
Finally, a closed wound vacuum reservoir was inserted and placed
in the cul-de-sac. All trocars were removed under direct visuali-
zation. Adequate suturing was performed to approximate the fascia
and subcutaneous tissues.
The preoperative characteristics that may have an inﬂuence on
surgical outcomes were age, body mass index history of abdominal
surgery, and identities of the myomas (Table 1). The important time
intervals were the following: (1) docking time, deﬁned as the time
spent attaching the robotic camera and arms to the previously
placed trocar sites; (2) console time, deﬁned as the time spent
operating at the robotic console, including enucleation time and
suture time; 3) morcellation time, deﬁned as the time spentretrieving the specimen by morcellation and the laparoscopic
grasper; (4) total operative time, deﬁned as the time from skin
incision to skin closure; and (5) total anesthesia time, deﬁned as the
time from intubation to awakening (Table 2). The outcome mea-
sures were estimated blood loss, transfusion rates, conversion rate,
complications rate, and the duration of the postoperative hospital
stay (Table 3).
Statistical analysis
In our study, mean and standard deviationwere used to describe
normal distribution, and the median and interquartile range were
used for nonnormal distribution. The mean docking time in
different time frames was compared using independent sample t
tests. All statistical analyses were performed using SPSS statistical
software version 19.0 for Windows (SPSS, Inc., Chicago, IL, USA). A
p value <0.05 was considered statistically signiﬁcant.
Table 2
Robotic surgical details.
Docking time (min) 20.8 ± 9.9 (7e40)
Enucleation time (min) 72.8 ± 53.8 (5e233)
Suture time (min) 69.6 ± 23.8 (20e110)
Console time (min) 142.4 ± 63.8 (42e283)
Morcellation time (min) 71.8 ± 28.0 (20e137)
Total operative time (skin to skin) (min) 278.6 ± 67.0 (110e415)
Total anesthesia time (min) 323.8 ± 64.9 (180e460)
All data are shown as the mean ± standard deviation (minimumemaximum).
Table 3
Surgical outcomes.
Estimated blood loss (mL) 235.7 ± 283.3
Transfusion rates, n (%) 5 (23.8%)
Postoperative hospital stay (d) 3.1 ± 0.9
Conversion rate, n (%) 0
Complications rate (%) 1 (4.8%)
H.-Y. Cheng et al. / Taiwanese Journal of Obstetrics & Gynecology 54 (2015) 39e42 41Results
Between October 2010 and March 2012, 21 consecutive RALMs
were performed at our institution. The average age of the 21
women in this study was 40.1 years (range, 32e48 years), and their
mean body mass index was 24.1 kg/m2 (range, 18.4e35.16 kg/m2).
The maximum ﬁbroid size was 17.9 cm and the maximum
ﬁbroid number in a single patient was 17. The mean total operative
time was 278.57 minutes (range, 110e415 minutes). The mean
intraoperative blood loss was 235.7 ± 283.3 mL. Five patients
(23.8%) received a blood transfusion after surgery. The mean
postoperative hospitalization time was 3.1 ± 0.9 days. No patient
required conversion to either a minilaparotomy or conventional
open surgery. The postoperative course was unremarkable in all
patients, and the passage of ﬂatus was on schedule. There was no
morbidity directly related to the robotic system. Only one patient
presented with a wound complication of focal erythema and slight
tenderness during outpatient clinic follow up. She received oral
antibiotic treatment for mild wound cellulitis.Discussion
Our study offers evidence that robotic-assisted laparoscopy
provides surgeons with the capability to handle complex myo-
mectomies and extends the capabilities of minimally invasive sur-
gery to include larger ﬁbroid size, greater ﬁbroid numbers, and
more complicated intra-abdominal conditions. In fact, the robotic-
assisted surgical system is an emerging technology with a wide
application in various surgical ﬁelds. Its superiority in intuitive
manipulation and its real stereopicture have allowed it to become
quickly adoptedworldwide [10]. The robotic surgery system has the
same advantages as laparoscopic surgery, including less morbidity,
less pain, and reduced postoperative adhesion formation [11]. It has
signiﬁcantly improved the operative performance of myomectomy
in providing delicate dissection and a stronger suture [12]. It is not
difﬁcult for skilled endoscopic surgeons to cross the threshold as
long as they are familiar with the robotic operating arms. Other
minor constituents of the learning curve may be related to ac-
commodating the three-dimensional vision and interaction be-
tween the console surgeon and team members at the operating
table. However, the lack of tactile sensation and force feedback is
the Achilles heel of the robotic surgical system and may lead to
invisible tissue damage during the surgery [13]. This drawback can
be compensated for by the visual information and accumulated
experience of the surgeons and can ultimately facilitate the surgery.In this study, we have presented our surgical experience from
preoperative information to intraoperative data and postoperative
outcomes. In accordance with recent studies [14,15], we have
shown that robotic-assisted surgery can provide an efﬁcacious
outcome for patients undergoing myomectomy, especially with
regard to the low morbidity rate and short hospital stay (3.1 ± 0.9
days). The robotic technique has been demonstrated to promote
surgical performance, particularly for quick and precise suturing of
uterine incisions. This meticulous and strong closure improves
hemostasis and reduces blood loss, successfully overcoming the
adversity formerly encountered in LM [16,17]. There is indeed some
evidence supporting the claim that robotic-assisted surgery is
associated with a low incidence of blood transfusion [18]. The re-
sults of our series seemed to show less operative blood loss than
that of other LM experiences in previous studies [19]. Five patients
in our study received a blood transfusion postoperatively. Three of
these patients had an imperative indication for transfusion due to
greater blood loss during surgery (>500 mL). The maximal size of
the ﬁbroids in these patients was 14.0 cm, 13.7 cm, and 6.5 cm,
respectively, and the total number of ﬁbroids was one, three, and
three, respectively. The other two patients received a blood trans-
fusion mainly due to menorrhagia-induced chronic anemia that
existed before the surgery. Nevertheless, the lack of a comparison
group of LM patients limited our ability to deﬁnitely state the po-
tential advantages of RALM in hemostasis and reducing intra-
operative blood loss in comparison with laparoscopic surgery.
With the exception of one case that presented with post-
operative infection, therewas no obviousmorbidity or complication
speciﬁcally related to the robotic access. Moreover, none of the pa-
tients in our study required conversion to either a minilaparotomy
or conventional open surgery, and this emphasizes the safety and
effectiveness of the robotic surgical system in dealing with complex
uterine ﬁbroids. Overall, postoperative hospitalization was rela-
tively short and there were no extreme cases. Rapid recovery after
robotic surgery was the main reason for the short hospital stay, and
no conversion to laparotomy was also an indirect cause. As we have
clearly observed, a dedicated operating room equipped with a ro-
botic surgery systemand a proﬁcient team can speed up each step of
the surgery. Our mean docking time was 27.1 minutes in the ﬁrst 6
months, and with growing experience, the setup time was reduced
to 15 minutes in the following 12 months (p < 0.05).
However, some reported evidence has shown that RALM is not
more beneﬁcial than LM with respect to short-term outcomes
[19,20]. In addition, robotic-assisted laparoscopic surgery is far
more costly than laparoscopy or laparotomy; therefore, its cost
effectiveness is not well established [21]. However, there may still
be some long-term potential advantages of RALM, which should be
investigated with more clinical cases and long-term follow up. The
unique level of precision in RALM could help to achieve complete
tissue excision and decrease the chances of a possible uterine
rupture or tearing during future pregnancies. Furthermore, RALM
enables the surgeon to address complex conditions such as large
adenomyomas, severe pelvic adhesion, bleeding, or urinary tract
injury [22,23]. Therefore, conversion to an open abdominal excision
is less likely, even in difﬁcult situations.Women of reproductive age
are usually concerned about the cosmetic effect, reproductive
outcome, and future recurrence after myomectomy surgery. RALM
appears to meet these requirements better than LM. However,
more prospective trials are needed in these areas of interest.
An additional value of robotic assistance is that it may be used
for complex diseases that require more delicate maneuvering (e.g.,
tubal anastomosis, severe adhesion, and oncologic surgery) [24].
The robotic surgical technique offers gynecologic surgeons a plat-
form for executing complex procedures with less morbidity, and
perhaps, with improved surgical outcomes.
H.-Y. Cheng et al. / Taiwanese Journal of Obstetrics & Gynecology 54 (2015) 39e4242In conclusion, our data clearly support the safety and feasibility
of the robotic technique in complex myomectomy surgery. The
analysis showed satisfactory surgical outcomes in terms of a low
morbidity rate, low conversion rate, and short hospitalization time.
However, the published data are preliminary results, and a long-
term follow-up study is required to completely appreciate the
contribution and impact of RALM.
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